• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶对革兰阴性杆菌体外抗菌活性的多中心研究

[Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli].

作者信息

Deforges L, Le Van Thoi J, Soussy C J, Duval J, Thabaut A, Meyran M, Acar J F, Kitzis M D, Fleurette J, Coulet M

出版信息

Pathol Biol (Paris). 1983 May;31(5):375-8.

PMID:6353327
Abstract

This work reports a multicenter study of antibacterial activity of ceftazidime, a new third generation cephalosporin, on hospital Gram negative rods. Enterobacteriaceae are very sensitive to ceftazidime with a maximum number of strains inhibited by 1 microgram/ml or less (modal MIC 0, 125 microgram/ml); some resistant strains are observed, particularly among Enterobacter and Citrobacter. Activity of ceftazidime on Pseudomonas aeruginosa is superior to other third generation cephalosporins; modal MIC is 1 microgram/ml and 88% of the strains are inhibited by 4 microgram/ml or less. Acinetobacter are less sensitive to ceftazidime, with a modal MIC of 8 microgram/ml.

摘要

本研究报告了一项关于新型第三代头孢菌素头孢他啶对医院革兰氏阴性杆菌抗菌活性的多中心研究。肠杆菌科对头孢他啶非常敏感,大多数菌株在1微克/毫升或更低浓度时受到抑制(最低抑菌浓度模式值为0.125微克/毫升);观察到一些耐药菌株,尤其是在肠杆菌属和柠檬酸杆菌属中。头孢他啶对铜绿假单胞菌的活性优于其他第三代头孢菌素;最低抑菌浓度模式值为1微克/毫升,88%的菌株在4微克/毫升或更低浓度时受到抑制。不动杆菌对头孢他啶不太敏感,最低抑菌浓度模式值为8微克/毫升。

相似文献

1
[Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli].头孢他啶对革兰阴性杆菌体外抗菌活性的多中心研究
Pathol Biol (Paris). 1983 May;31(5):375-8.
2
[In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study].
Pathol Biol (Paris). 1983 Jun;31(6):488-91.
3
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].[头孢甲肟(SCE 1365)对616株因对β-内酰胺耐药而挑选出的医院革兰氏阴性杆菌的体外活性。与头孢噻肟、拉氧头孢和头孢他啶的比较]
Pathol Biol (Paris). 1983 May;31(5):351-6.
4
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].头孢曲松、头孢噻肟和拉氧头孢对150株革兰氏阴性菌的比较研究(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):341-4.
5
[Multicenter study of the antibacterial activity of a new cephalosporin: CM 40874].一种新型头孢菌素(CM 40874)抗菌活性的多中心研究
Pathol Biol (Paris). 1984 May;32(5):331-4.
6
[In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].八种第三代头孢菌素的体外抗菌活性(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):363-9.
7
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).头孢吡肟对北美医院耐头孢他啶革兰阴性临床菌株的抗菌活性:哨兵抗菌监测计划(1998 - 2004年)报告
Diagn Microbiol Infect Dis. 2006 Sep;56(1):63-8. doi: 10.1016/j.diagmicrobio.2006.02.009. Epub 2006 May 2.
8
[In vitro activity of carumonam (RO 17-2301) on hospital bacteria].卡芦莫南(RO 17 - 2301)对医院细菌的体外活性
Pathol Biol (Paris). 1986 Jun;34(5 Pt 2):573-6.
9
Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.第三代头孢菌素:对常规临床分离株的抗菌活性比较
N Z Med J. 1982 Jun 23;95(710):414-6.
10
A comparative study of the in-vitro activity of cefepime and other cephalosporins.头孢吡肟与其他头孢菌素体外活性的比较研究。
Malays J Pathol. 1993 Jun;15(1):65-8.